A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive.

Trial Profile

A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Budesonide (Primary) ; Budesonide (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions
  • Sponsors AstraZeneca; Perrigo
  • Most Recent Events

    • 20 Oct 2014 The patient number is given as 110 in Eudra and 126 in CT.gov; retained as CT.gov because it was greater than Eudra.
    • 01 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Jul 2014 Planned End Date changed from 1 Oct 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top